Atlas Venture, a leading early stage venture capital firm, announced today that Samantha (Sam) Truex is joining the firm as a venture partner. Sam will work with the Atlas team to start and build new biotech companies aimed at bringing therapeutic innovations to patients.
Most of the titles in a biotech C-suite are generally self-explanatory. The Chief Technical and Manufacturing Officer runs operations in CMC and analytics. The Chief Financial Officer handles financial strategy and investor relations. The Chief Commercial Officer prepares for bringing investigational therapies to market.
By Deanna Petersen, Chief Business Officer of AVROBIO, as part of the From The Trenches feature of LifeSciVC
The role of the core in making an organization great and how we do right by them.
Small organizations are amazing for the impact they can have relative to their size.
By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC
Despite saving the world from COVID, pharma and biotech are still in the crosshairs of many politicians. With many anti-Pharma politicians and regulators emboldened in the current environment, and with more aggressive tax and spending policy in the works, there a number of risks to biotech over the next 1-2 years out of Washington.
Another quarter, another set of all-time highs for biotech funding – and this surfeit of capital continues raises possible concerns about its disciplined deployment.